BioSpace News Archive

Nexstim Plc Receives R&D Loan From Business Finland

To enable extensive therapeutic use of the NBT System, the project is a major part of Nexstim’s commercialisation process of its therapeutic products.

January 23, 2018
·
3 min read
Bone Therapeutics SA : Provides Business Outlook and Announces Its Financial Calendar for 2018

The Company started 2018 with EUR 8.4 million in cash.

January 23, 2018
·
5 min read
Biotech Bay

Portola Pharmaceuticals Announces Acceptance of Late-Breaker Abstract Highlighting New Data for Andexanet Alfa at ACC.18

The data will be presented on Monday, March 12, 2018 at 11:30 a.m. ET.

January 23, 2018
·
4 min read
Genetown

BeiGene Announces Closing of $800M Public Offering

BeiGene intends to use proceeds from the offering for working capital and general corporate purposes, including research and development activities.

January 23, 2018
·
3 min read
Profounda Launches Rhinase Baby Lubricating Nasal Drops

Profounda announced today that Rhinase Baby Lubricating Nasal Drops is now available in the United States through Rhinase.com and Amazon.com as well as on retail shelves at Kinney Drugs. Patients can also ask their Pharmacists to order Rhinase products directly from Profounda or Cardinal Health.

January 23, 2018
·
2 min read
Policy

BioUtah Applauds Congressional Passage of Two-Year Delay of the Medical Device Tax

The CR delays the tax for 2018 and 2019, retroactive to January 1. Upon passage, Kelly Slone, President and CEO, BioUtah, issued the following statement.

January 23, 2018
·
1 min read
Business

Marken Opens New Location In Stuttgart, Germany

Marken today announced it will open a third branch in Germany in the first quarter of 2018 to meet new demands in the region.

January 23, 2018
·
2 min read
Deals

CanniMed Therapeutics Announces Continued Discussions with Aurora

CanniMed Therapeutics Inc. announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc.

January 23, 2018
·
3 min read
Cardiome Announces Expanded Label for Aggrastat in China Including New STEMI Indication and High Dose Bolus Regimen

In addition to the expanded indications, the CDE also approved an Aggrastat high dose bolus regimen to be used on both indicated patient populations.

January 23, 2018
·
8 min read
Business

Gritstone Oncology Appoints Jean-Marc Bellemin as Chief Financial Officer

Gritstone Oncology announced today the appointment of Jean-Marc Bellemin as Executive Vice President of Finance and Chief Financial Officer, effective January 5, 2018.

January 23, 2018
·
3 min read